Product References
SerpinB3 drives cancer stem cell survival in glioblastoma.
Cell reports
Lauko A,Volovetz J,Turaga SM,Bayik D,Silver DJ,Mitchell K,Mulkearns-Hubert EE,Watson DC,Desai K,Midha M,Hao J,McCortney K,Steffens A,Naik U,Ahluwalia MS,Bao S,Horbinski C,Yu JS,Lathia JD
PA5-30164 was used in Immunohistochemistry to identify a GBM CSC-specific survival mechanism involving a cysteine protease inhibitor, SerpinB3, and provide a potential target to improve the efficacy of GBM therapies against therapeutically resistant CSCs.
Tue Sep 13 00:00:00 EDT 2022
SerpinB3 drives cancer stem cell survival in glioblastoma.
Cell reports
Lauko A,Volovetz J,Turaga SM,Bayik D,Silver DJ,Mitchell K,Mulkearns-Hubert EE,Watson DC,Desai K,Midha M,Hao J,McCortney K,Steffens A,Naik U,Ahluwalia MS,Bao S,Horbinski C,Yu JS,Lathia JD
PA5-30164 was used in Immunohistochemistry to identify a GBM CSC-specific survival mechanism involving a cysteine protease inhibitor, SerpinB3, and provide a potential target to improve the efficacy of GBM therapies against therapeutically resistant CSCs.
Tue Sep 13 00:00:00 EDT 2022
SerpinB3 drives cancer stem cell survival in glioblastoma.
Cell reports
Lauko A,Volovetz J,Turaga SM,Bayik D,Silver DJ,Mitchell K,Mulkearns-Hubert EE,Watson DC,Desai K,Midha M,Hao J,McCortney K,Steffens A,Naik U,Ahluwalia MS,Bao S,Horbinski C,Yu JS,Lathia JD
PA5-30164 was used in Immunohistochemistry to identify a GBM CSC-specific survival mechanism involving a cysteine protease inhibitor, SerpinB3, and provide a potential target to improve the efficacy of GBM therapies against therapeutically resistant CSCs.
Tue Sep 13 00:00:00 EDT 2022
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation.
Cellular and molecular gastroenterology and hepatology
Foglia B,Sutti S,Cannito S,Rosso C,Maggiora M,Autelli R,Novo E,Bocca C,Villano G,Ramavath NN,Younes R,Tusa I,Rovida E,Pontisso P,Bugianesi E,Albano E,Parola M
PA5-30164 was used immunohistochemistry (paraffin) investigate the involvement of hepatocyte HIF-2α in experimental nonalcoholic steatohepatitis (NASH)-related carcinogenesis.
Mon Apr 04 00:00:00 EDT 2022